참고문헌
- Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:307-327. https://doi.org/10.1016/S0889-8553(01)00019-X
- Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454-459. https://doi.org/10.1001/archinte.1976.03630040056012
- Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-183. https://doi.org/10.1097/00005792-199372030-00003
- Higenbottam T, Cochrane GM, Clark TJ, Turner D, Millis R, Seymour W. Bronchial disease in ulcerative colitis. Thorax 1980;35:581-585. https://doi.org/10.1136/thx.35.8.581
- Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging 1993;8:159-163. https://doi.org/10.1097/00005382-199321000-00010
- Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429. https://doi.org/10.1056/NEJMra020831
- Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-1608. https://doi.org/10.1053/gast.2002.33426
- Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-523. https://doi.org/10.1097/00054725-200606000-00012
- Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, Akeson AL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L134-L142. https://doi.org/10.1152/ajplung.00050.2004
- Songur N, Songur Y, Tuzun M, et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003;37:292-298. https://doi.org/10.1097/00004836-200310000-00006
- Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41-48. https://doi.org/10.1183/09031936.00.15104100
- Marvisi M, Borrello PD, Brianti M, Fornarsari G, Marani G, Guariglia A. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000;16:965-968. https://doi.org/10.1183/09031936.00.16596500
- Fireman Z, Osipov A, Kivity S, et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn’s disease. Am J Gastroenterol 2000;95:730-734. https://doi.org/10.1111/j.1572-0241.2000.01843.x
- Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007;13:5581-5593. https://doi.org/10.3748/wjg.v13.i42.5581
- Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803. https://doi.org/10.1016/S0016-5085(89)80079-4
- Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-249.
- Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258(4 Pt 1):G527-G534.
- Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999;116:238-245. https://doi.org/10.1046/j.1365-2249.1999.00878.x
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
- Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104-115. https://doi.org/10.1097/00054725-200303000-00004
- Bewig B, Manske I, Bottcher H, Bastian A, Nitsche R, Folsch UR. Crohn's disease mimicking sarcoidosis in bronchoalveolar lavage. Respiration 1999;66:467-469. https://doi.org/10.1159/000029413
- te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006;12:995-999. https://doi.org/10.1097/01.mib.0000227817.54969.5e
- Komai H, Naito Y, Okamura Y. Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery. Perfusion 2005;20:77-82. https://doi.org/10.1191/0267659105pf788oa
- Hocking D, Ferro TJ, Johnson A. Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema. J Appl Physiol (1985) 1992;72:179-185. https://doi.org/10.1152/jappl.1992.72.1.179
- Gursoy S, Guven K, Kula M, et al. Subclinical alveolar involvement in ulcerative colitis. Inflamm Bowel Dis 2005;11:372-375. https://doi.org/10.1097/01.MIB.0000164019.83666.af
- Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999;5:119-133. https://doi.org/10.1097/00054725-199905000-00008
피인용 문헌
- Lung injury as an extra-intestinal manifestation of inflammatory bowel disease vol.31, pp.5, 2016, https://doi.org/10.3904/kjim.2016.266
- IL-6 Drives Neutrophil-Mediated Pulmonary Inflammation Associated with Bacteremia in Murine Models of Colitis vol.188, pp.7, 2016, https://doi.org/10.1016/j.ajpath.2018.03.016
- Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome vol.12, pp.4, 2016, https://doi.org/10.1038/s41385-019-0163-3
- Inflammatory bowel disease and the lung in paediatric patients vol.17, pp.1, 2016, https://doi.org/10.1183/20734735.0269-2020